Extrastriatal dopaminergic dysfunction in tourette syndrome
暂无分享,去创建一个
Ji Hyun Ko | Sylvain Houle | Pablo Rusjan | Antonio P Strafella | Paul Sandor | S. Houle | A. Strafella | A. Lang | P. Sandor | J. Ko | P. Rusjan | David M Kideckel | T. Steeves | Anthony E Lang | Thomas D L Steeves | David M. Kideckel | David M. Kideckel
[1] C. Nicholson,et al. Amphetamine Distorts Stimulation-Dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores , 2001, The Journal of Neuroscience.
[2] D. Ingvar,et al. COMPULSORY SHOUTING (BENEDEK'S “KLAZOMANIA”) ASSOCIATED WITH OCULOGYRIC SPASMS IN CHRONIC EPIDEMIC ENCEPHALITIS , 1961, Acta psychiatrica Scandinavica.
[3] A Rothenberger,et al. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. , 1997, The American journal of psychiatry.
[4] K Suzuki,et al. Reproducibility of [11C]FLB 457 binding in extrastriatal regions , 2001, Nuclear medicine communications.
[5] J. Mazziotta,et al. MRI‐PET Registration with Automated Algorithm , 1993, Journal of computer assisted tomography.
[6] A. Grace. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.
[7] J. Jankovic,et al. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias , 1988, Neurology.
[8] R. Wightman,et al. Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.
[9] S. Pulst,et al. Carbon monoxide poisoning with features of Gilles de la Tourette's syndrome. , 1983, Archives of neurology.
[10] B. Vogt,et al. Contributions of anterior cingulate cortex to behaviour. , 1995, Brain : a journal of neurology.
[11] D. Gilbert,et al. Tic reduction with pergolide in a randomized controlled trial in children , 2003, Neurology.
[12] A. Antonini,et al. The metabolic anatomy of Tourette's syndrome , 1997, Neurology.
[13] H. Fibiger,et al. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[14] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[15] F. Tarazi,et al. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. , 2001, The Journal of pharmacology and experimental therapeutics.
[16] W. Goodman,et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.
[17] Mark Hallett,et al. Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results , 1996, Biological Psychiatry.
[18] A. Braun,et al. The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness , 1995, Neuropsychopharmacology.
[19] T. Paus,et al. Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brain-mapping meta-analysis , 2000, Experimental Brain Research.
[20] Peter Herscovitch,et al. The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. I. Regional Changes in Cerebral Glucose Metabolism Differentiating Patients and Controls , 1993, Neuropsychopharmacology.
[21] Claus Svarer,et al. Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. , 2007, The international journal of neuropsychopharmacology.
[22] Karl J. Friston,et al. A unified statistical approach for determining significant signals in images of cerebral activation , 1996, Human brain mapping.
[23] A. Anderson,et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. , 1998, Archives of general psychiatry.
[24] J. Jankovic,et al. Long-term effects of tetrabenazine in hyperkinetic movement disorders , 1997, Neurology.
[25] Jeffrey M Albert,et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. , 2007, Journal of neurosurgery.
[26] M. Hamilton,et al. Rating depressive patients. , 1980, The Journal of clinical psychiatry.
[27] S Geier,et al. [Behavioral manifestations induced by electric stimulation of the anterior cingulate gyrus in man]. , 1976, Revue neurologique.
[28] J. R. Augustine. Circuitry and functional aspects of the insular lobe in primates including humans , 1996, Brain Research Reviews.
[29] Nir Giladi,et al. Ropinirole in Gilles de la Tourette syndrome , 2004, Neurology.
[30] E M Wassermann,et al. Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. , 2001, Advances in neurology.
[31] L. Cubeddu,et al. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. , 1988, The Journal of pharmacology and experimental therapeutics.
[32] D. Weinberger,et al. Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. , 1998, Neurology.
[33] G Bernardi,et al. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. , 1993, Brain : a journal of neurology.
[34] M Hallett,et al. Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. , 2006, Brain : a journal of neurology.
[35] D. Durstewitz,et al. Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons , 2001, The Journal of Neuroscience.
[36] Yun Zhou,et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. , 2002, The American journal of psychiatry.
[37] Z. Kruk,et al. Differential action of (+)‐amphetamine on electrically evoked dopamine overflow in rat brain slices containing corpus striatum and nucleus accumbens , 1994, British journal of pharmacology.
[38] Eric M. Wassermann,et al. Transcranial Magnetic Stimulation-Evoked Cortical Inhibition: A Consistent Marker of Attention-Deficit/Hyperactivity Disorder Scores in Tourette Syndrome , 2005, Biological Psychiatry.
[39] M. Robertson,et al. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[40] M. Trimble,et al. Dopamine receptor availability in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.
[41] R. Narendran,et al. Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride , 2009, Synapse.
[42] G. Stebbins,et al. Talipexole and adult Gilles de la tourette's syndrome: Double‐blind, placebo‐controlled clinical trial , 1994, Movement disorders : official journal of the Movement Disorder Society.
[43] J. Mink,et al. Response to levodopa challenge in Tourette syndrome , 2000, Movement disorders : official journal of the Movement Disorder Society.
[44] C. Olson,et al. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. , 1992, Cerebral cortex.
[45] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[46] Karl J. Friston,et al. Cortical areas and the selection of movement: a study with positron emission tomography , 1991, Experimental Brain Research.
[47] C. McDougle,et al. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. , 1995, The American journal of psychiatry.
[48] Neal R. Swerdlow,et al. Tactile prepuff inhibition of startle in children with Tourette’s syndrome: in search of an “fMRI-friendly” startle paradigm , 2001, Biological Psychiatry.
[49] E Stern,et al. A functional neuroanatomy of tics in Tourette syndrome. , 2000, Archives of general psychiatry.
[50] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[51] B. Carroll,et al. Effects of dopamine agonists and antagonists in Tourette's disease. , 1979, Archives of general psychiatry.
[52] M. Laruelle. Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[53] D. Barch,et al. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study , 2004, Biological Psychiatry.
[54] E. Phelps,et al. "Willed action": a functional MRI study of the human prefrontal cortex during a sensorimotor task. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[55] H. Singer,et al. Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum , 2004, Journal of the Neurological Sciences.
[56] Matti Laine,et al. Frontal and Temporal Dopamine Release during Working Memory and Attention Tasks in Healthy Humans: a Positron Emission Tomography Study Using the High-Affinity Dopamine D2 Receptor Ligand [11C]FLB 457 , 2005, The Journal of Neuroscience.
[57] R. Coppola,et al. Tourette Syndrome: Prediction of Phenotypic Variation in Monozygotic Twins by Caudate Nucleus D2 Receptor Binding , 1996, Science.
[58] D. Sulzer,et al. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[59] L. Descarries,et al. Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study , 1993, Brain Research.
[60] G. Sethuraman,et al. Dopamine agonist treatment of tourette disorder in children: Results of an open‐label trial of pergolide , 1997, Movement disorders : official journal of the Movement Disorder Society.
[61] J. Talairach,et al. The cingulate gyrus and human behaviour. , 1973, Electroencephalography and clinical neurophysiology.
[62] Anthony A Grace,et al. Opposite Influences of Endogenous Dopamine D1 and D2 Receptor Activation on Activity States and Electrophysiological Properties of Striatal Neurons: Studies CombiningIn Vivo Intracellular Recordings and Reverse Microdialysis , 2002, The Journal of Neuroscience.
[63] K. Worsley,et al. A Statistical Method for the Analysis of Positron Emission Tomography Neuroreceptor Ligand Data , 2000, NeuroImage.
[64] D. Pauls. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. The Tourette Syndrome Association International Consortium for Genetics. , 1999, American journal of human genetics.
[65] Christer Halldin,et al. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients , 1997, Psychopharmacology.
[66] J. Leckman,et al. Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis , 2007, Journal of the Neurological Sciences.
[67] H. Singer,et al. Executive function in fluency and recall measures among children with Tourette syndrome or ADHD , 2001, Journal of the International Neuropsychological Society.
[68] Andreas Heinz,et al. Tourette's syndrome , 1998, Neurology.
[69] Albert Gjedde,et al. Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET , 2008, Neuropsychopharmacology.
[70] Peter Herscovitch,et al. The Functional Neuroanatomy of Tourette's Syndrome: An FDG PET Study III: Functional Coupling of Regional Cerebral Metabolic Rates , 2002, Neuropsychopharmacology.
[71] V. Visser-Vandewalle,et al. Deep brain stimulation in Tourette's syndrome: Two targets? , 2006, Movement disorders : official journal of the Movement Disorder Society.
[72] E Wyllie,et al. Functional anatomy of the human supplementary sensorimotor area: results of extraoperative electrical stimulation. , 1994, Electroencephalography and clinical neurophysiology.
[73] F. Tarazi,et al. Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: Common targets for typical and atypical antepsychotic drugs , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[74] B. Christian,et al. Altered mesolimbocortical and thalamic dopamine in Tourette syndrome , 2006, Neurology.
[75] D. Collins,et al. Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space , 1994, Journal of computer assisted tomography.
[76] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[77] E. L. Harris,et al. Executive function in children with Tourette Syndrome and/or Attention Deficit Hyperactivity Disorder , 1995, Journal of the International Neuropsychological Society.
[78] P. Calabresi,et al. Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats , 1988, Neuroscience.
[79] T. Reader,et al. Dopamine Receptor Agonists Regulate Levels of the Serotonin 5-HT2A Receptor and its mRNA in a Subpopulation of Rat Striatal Neurons , 1996, The Journal of Neuroscience.
[80] T. Ullrich,et al. Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism , 2004, Journal of Pharmacology and Experimental Therapeutics.
[81] G. Sawle,et al. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[82] Linda J. Schuerholz,et al. Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder , 1996, Neurology.
[83] S. Leurgans,et al. Advantages of a modified scoring method for the rush video‐based tic rating scale , 1999, Movement disorders : official journal of the Movement Disorder Society.
[84] A. Gjedde,et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[85] H. Emrich,et al. Serotonin transporter binding in Tourette Syndrome , 2005, Neuroscience Letters.
[86] S. Robertson,et al. A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters , 2009, Molecular Neurobiology.
[87] J C Rothwell,et al. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine. , 2005, Brain : a journal of neurology.
[88] P. Roland,et al. Supplementary motor area and other cortical areas in organization of voluntary movements in man. , 1980, Journal of neurophysiology.